Eph receptor tumor biomarkers

Details for Australian Patent Application No. 2005299767 (hide)

Owner The Penn State Research Foundation

Inventors Gibo, Denise; Wykosky, Jill; Debinski, Waldemar

Agent Collison & Co

Pub. Number AU-A-2005299767

PCT Pub. Number WO2006/047298

Priority 60/620,952 21.10.04 US

Filing date 21 October 2005

Wipo publication date 4 May 2006

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/047298 Priority application(s): WO2006/047298

19 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299771-Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use

2005299765-System, chamber, and method for fractionation and elutriation of fluids containing particulate components